Eli Lilly CEO David Ricks on Q2 results: Seeing unbelievable demand for Zepbound and Mounjaro CNBC TelevisionEli Lilly Stock Surges as Mounjaro and Zepbound Drugs Fuel Sales The Wall Street JournalEli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar CNBCWeight-loss drug powers Lilly results, 2024 forecast raised by $3 billion ReutersEli Lilly stock jumps on GLP-1 sales, end of manufacturing shortage Yahoo Finance